Ni Putu Sri Indrani Remitha

6PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 07, 2026
A Network Meta-Analysis Comparing the Efficacy of Lenvatinib, Atezolizumab plus Bevacizumab, and Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma.

Ni Putu Sri Indrani Remitha, I Gede Aswin Parisya Sasmana, I Komang Wira Ananta Kusuma

|Nov 28, 2025
Prognostic Significance of Up-to-Seven Criteria Versus Milan Criteria for Hepatocellular Carcinoma Patients Undergoing Resection or Locoregional Therapy: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, I Komang Wira Ananta Kusuma, I Gede Aswin Parisya Sasmana

|Jun 21, 2025
Efficacy of Lenvatinib Versus Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, Ni Putu Rista Pradnya Dewi, I Komang Chandra Yogananda

|May 29, 2025
Efficacy and Safety of Lenvatinib versus Atezolizumab Plus Bevacizumab in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Ni Putu Sri Indrani Remitha, Ni Putu Rista Pradnya Dewi, I Komang Wira Ananta Kusuma

|Dec 29, 2024
Correlation of CD44 Protein Expression with Larger Tumor Size and Advanced Stage of Breast Cancer Patients.

Desak Made Wihandani, Ida Ayu Dewi Wiryanthini, Made Violin Weda Yani

|May 28, 2022
Pretreatment Leukocyte Count Ratios as Metastatic Predictive Factors in Luminal Type Breast Cancer.

I Gede Wikania Wira Wiguna, Ni Putu Sri Indrani Remitha, I Gusti Ayu Stiti Sadvika

Pageof 1